Dazoxiben
Dazoxiben is a potent and orally active thromboxane synthetase inhibitor. Dazoxiben has the potential for the research of Raynaud's syndrome[1].
Product Specifications
CAS Number
78218-09-4
Product Name Alternative
UK 37248 (free base)
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
Prostaglandin Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Assay Protocol
https://www.medchemexpress.com/dazoxiben-1.html
Smiles
OC(C1=CC=C(OCCN2C=CN=C2)C=C1)=O
Molecular Formula
C12H12N2O3
Molecular Weight
232.24
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
[1]Belch JJ, et al. Dazoxiben, a thromboxane synthetase inhibitor, in the treatment of Raynaud's syndrome: a double-blind trial. Br J Clin Pharmacol. 1983;15 Suppl 1 (Suppl 1) :113S-116S.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog